These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 6295387)

  • 1. Characterization of dopamine receptors by 3H-ADTN binding in calf adrenal zona glomerulosa.
    Bevilacqua M; Vago T; Scorza D; Norbiato G
    Biochem Biophys Res Commun; 1982 Oct; 108(4):1661-9. PubMed ID: 6295387
    [No Abstract]   [Full Text] [Related]  

  • 2. Properties of dopamine agonist and antagonist binding sites in mammalian retina.
    Makman MH; Dvorkin B; Horowitz SG; Thal LJ
    Brain Res; 1980 Aug; 194(2):403-18. PubMed ID: 6770965
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Binding of 3H-ADTN, a dopamine agonist, to membranes of the bovine retina.
    Osborne NN
    Cell Mol Neurobiol; 1981 Jun; 1(2):167-74. PubMed ID: 7346167
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Similar binding of 3H-ADTN and 3H-apomorphine to calf brain dopamine receptors.
    Seeman P; Woodruff GN; Poat JA
    Eur J Pharmacol; 1979 Apr; 55(2):137-42. PubMed ID: 456412
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Striatal binding of 2-amino-6,7-[3H]dihydroxy-1,2,3,4-tetrahydronaphthalene to two dopaminergic sites distinguished by their low and high affinity for neuroleptics.
    List SJ; Wreggett KA; Seeman P
    J Neurosci; 1982 Jul; 2(7):895-906. PubMed ID: 6124583
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of ADTN to define specific 3H-spirerone binding to receptors in brain.
    Quik M; Iversen LL; Larder A; Mackay AV
    Nature; 1978 Aug; 274(5670):513-4. PubMed ID: 672981
    [No Abstract]   [Full Text] [Related]  

  • 7. [3H] 2-Amino-6,7-dihydroxy 1,2,3,4-tetrahydronapthalene (ADTN): a potential specific dopamine receptor ligand.
    Clement-Cormier Y; Abel M
    Res Commun Chem Pathol Pharmacol; 1978 Oct; 22(1):15-25. PubMed ID: 725314
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacology of high-affinity binding of [3H](+/-)2-amino-6,7-dihydroxy-1,2,3,4-tetrahydronaphthalene (ADTN) to bovine caudate nucleus tissue.
    Arana GW; Baldessarini RJ; Lamont JS; Amlicke D; Neumeyer JL
    Biochem Pharmacol; 1983 Oct; 32(19):2873-80. PubMed ID: 6626260
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Uptake of (3H)-ADTN into dopaminergic neurons in the rabbit retina.
    Ehinger B
    Acta Physiol Scand; 1981 Apr; 111(4):511-2. PubMed ID: 7304214
    [No Abstract]   [Full Text] [Related]  

  • 10. Effects of cations on high-affinity binding of 3H-ADTN to dopaminergic sites in calf caudate tissue.
    Lamont JS; Kula NS; Baldessarini RJ
    Neuropharmacology; 1987 Jun; 26(6):637-9. PubMed ID: 3601010
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ascorbic acid and membrane ageing: critical determinants of the in-vitro binding of [3H]ADTN to rat striatal tissue.
    Bradbury AJ; Costall B; Naylor RJ
    J Pharm Pharmacol; 1983 Nov; 35(11):738-45. PubMed ID: 6139456
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro binding of the very potent and selective D-2 dopamine agonist, [3H]N-0437 to calf caudate membranes.
    Van der Weide J; De Vries JB; Tepper PG; Horn AS
    Eur J Pharmacol; 1987 Feb; 134(2):211-9. PubMed ID: 3569410
    [TBL] [Abstract][Full Text] [Related]  

  • 13. S(-)DP-5,6-ADTN as an in vivo dopamine receptor ligand: relation between displacement by dopamine agonists and their pharmacological effects.
    Rollema H; Feenstra MG; Grol CJ; Lewis MH; Staples L; Mailman RB
    Naunyn Schmiedebergs Arch Pharmacol; 1986 Apr; 332(4):338-45. PubMed ID: 3736679
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The conformation of dopamine at its receptor: binding of monohydroxy-2-aminotetralin enantiomers and positional isomers.
    Tedesco JL; Seeman P; McDermed JD
    Mol Pharmacol; 1979 Sep; 16(2):369-81. PubMed ID: 514252
    [No Abstract]   [Full Text] [Related]  

  • 15. Binding of [3H]ADTN to rat striatal membranes.
    Templeton WW; Woodruff GN
    Biochem Pharmacol; 1982 Apr; 31(8):1629-32. PubMed ID: 6124259
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dopaminergic binding and inhibitory effect in the bovine adrenal zona glomerulosa.
    Stern N; Tuck M; Ozaki L; Krall JF
    Hypertension; 1986 Mar; 8(3):203-10. PubMed ID: 3005168
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective storage in vivo of 5,6-ADTN in dopamine-rich areas of the rat brain.
    Westerink BH; Dijkstra D; Feenstra MG; Horn AS; Rollema H
    Eur J Pharmacol; 1980 Jun; 64(2-3):115-21. PubMed ID: 7398758
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of D-2 dopaminergic receptors in bovine adrenal cortex.
    Missale C; Liberini P; Memo M; Carruba MO; Spano P
    Life Sci; 1985 Dec; 37(26):2539-48. PubMed ID: 4079661
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lack of effects of fibrinogen degradation products on specific binding of [3H]spiroperidol and [3H]ADTN.
    Buczko W; De Blasi A
    Pol J Pharmacol Pharm; 1983; 35(1):45-7. PubMed ID: 6889186
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential effects of ascorbate and EDTA on high-affinity binding of 3H-apomorphine and 3H-ADTN to calf caudate membranes.
    Arana GW; Baldessarini RJ; Kula NS
    Neuropharmacology; 1982 Jun; 21(6):601-4. PubMed ID: 6810198
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.